Clinical Trials · NCT06487832
Effect of GLP1 Receptor Agonist on Brain Insulin Responsiveness
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- University Hospital Tuebingen
- Enrollment
- 60
- Start date
- Jul 2024
- Locations
- 1 site, Germany
- Primary endpoint
- Cerebral response after insulin compared to placebo nasal spray